Michael Jirousek
Chief Operating Officer
Pharmaceuticals
Frequency Therapeutics
United States of America
Biography
Michael is the Chief Operating Officer of Frequency Therapeutics. Prior to Frequency, he co-founded Catabasis Pharmaceuticals and served as Chief Scientific Officer, where his contributions helped create several potential new therapeutics and guide the company to an IPO in 2015. During his almost 30-year career, Michael has overseen hundreds of R&D programs and has brought more than 15 new therapeutics from discovery into clinical study to address muscular dystrophy, dyslipidemia, cancer and a variety of metabolic diseases.
Research Interest
dystrophy, dyslipidemia, cancer and a variety of metabolic diseases.
